Tevogen Bio Inc: Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
Tevogen Bio ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN), is a clinical-stage specialty immunotherapy biotech company. As the biopharma industry ...
stocknews1d
3 Biotech Stocks Revolutionizing Healthcare
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...
Candel initiated at buy by Citi, lead immunotherapy drugs cited
BofA has initiated coverage of Candel Therapeutics (CADL) with a buy rating, citing the potential of its immunotherapy drug candidates CAN-2409 and CAN-3110. Read more here.
CERo Therapeutics Holdings, Inc. Highlights Progress
Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025 SOUTH SAN FRANSCISCO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdi ...